Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Taro Pharmaceutical (TARO)
NYSE:TARO
RESEARCH TOOLSreports
Holding TARO?
Track your performance easily
TARO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$32.67 - $45.76
Previous Close$42.97
Volume242.11K
Average Volume (3M)36.92K
Market Cap
$1.62B
Enterprise Value$884.81M
Total Cash (Recent Filing)$730.31M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)30.0
Beta0.59
Next Earnings
Jul 24, 2024EPS EstimateN/A
Last Dividend Ex-Date
Dec 10, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)1.43
Shares Outstanding37,580,000
10 Day Avg. Volume85,268
30 Day Avg. Volume36,921
Standard Deviation0.10
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.93
Price to Sales (P/S)2.82
Price to Cash Flow (P/CF)7.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.06
Enterprise Value/Gross Profit3.30
Enterprise Value/Ebitda18.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Taro Pharmaceutical News
PremiumCompany Announcements
Sun Pharma Announces Successful Taro Merger
PremiumPress Releases
Taro Shareholders Approve Merger with Sun Pharma
PremiumCompany Announcements
Taro Pharmaceutical Greenlights Merger With Sun Pharma
PremiumPress Releases
Taro Shareholders Approve Merger with Sun Pharma
PremiumCompany Announcements
Taro Pharmaceutical Reports Strong Fiscal Year
Ownership Overview
<0.01%
Insiders
2.60% Mutual Funds
3.99% Other Institutional Investors
93.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
TARO FAQ
What was Taro Pharmaceutical’s price range in the past 12 months?
Taro Pharmaceutical lowest stock price was $32.67 and its highest was $45.76 in the past 12 months.
What is Taro Pharmaceutical’s market cap?
Currently, no data Available
When is Taro Pharmaceutical’s upcoming earnings report date?
Taro Pharmaceutical’s upcoming earnings report date is Jul 24, 2024 which is 120 days ago.
How were Taro Pharmaceutical’s earnings last quarter?
Taro Pharmaceutical released its earnings results on May 20, 2024. The company reported $0.4 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.09.
Is Taro Pharmaceutical overvalued?
According to Wall Street analysts Taro Pharmaceutical’s price is currently Overvalued.
Does Taro Pharmaceutical pay dividends?
Taro Pharmaceutical pays a Notavailable dividend of $12.86 which represents an annual dividend yield of N/A. See more information on Taro Pharmaceutical dividends here
What is Taro Pharmaceutical’s EPS estimate?
Taro Pharmaceutical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Taro Pharmaceutical have?
Taro Pharmaceutical has 37,585,000 shares outstanding.
What happened to Taro Pharmaceutical’s price movement after its last earnings report?
Taro Pharmaceutical reported an EPS of $0.4 in its last earnings report, beating expectations of $0.31. Following the earnings report the stock price went up 0.236%.
Which hedge fund is a major shareholder of Taro Pharmaceutical?
Among the largest hedge funds holding Taro Pharmaceutical’s share is Brandes Investment Partners LP. It holds Taro Pharmaceutical’s shares valued at 12M.
---
Taro Pharmaceutical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
TARO Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 196.6K Shares
Last Quarter.
Last Quarter.
Fundamentals
Return on Equity
3.06%
Trailing 12-Months
Asset Growth
1.24%
Trailing 12-Months
Company Description
Taro Pharmaceutical
Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.
---
TARO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Dr Reddy's Laboratories
―
Perrigo Company
―
Protagonist Therapeutics
―
ANI Pharmaceuticals
―
---